The Therapeutic Effects of Bevacizumab in Patients with Polypoidal Choroidal Vasculopathy

PURPOSE: To evaluate the efficacy and safety of intravitreal bevacizumab for polypoidal choroidal vasculopathy (PCV). METHODS: In this retrospective interventional pilot study, 12 eyes of 11 patients with active PCV were treated with intravitreal bevacizumab (1.25 mg) alone or in combination with ph...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Sun Young, Kim, June-Gone, Joe, Soo Geun, Chung, Hyewon, Yoon, Young Hee
Formato: Texto
Lenguaje:English
Publicado: The Korean Ophthalmological Society 2008
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2629943/
https://www.ncbi.nlm.nih.gov/pubmed/18612226
http://dx.doi.org/10.3341/kjo.2008.22.2.92

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2629943/
https://www.ncbi.nlm.nih.gov/pubmed/18612226
http://dx.doi.org/10.3341/kjo.2008.22.2.92

Ejemplares similares